Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review

被引:103
作者
Guy, Rebecca [1 ,2 ]
Gold, Judy [2 ]
Calleja, Jesus M. Garcia [3 ]
Kim, Andrea A. [4 ]
Parekh, Bharat [5 ]
Busch, Michael [6 ]
Rehle, Thomas [7 ]
Hargrove, John [8 ]
Remis, Robert S. [9 ]
Kaldor, John M. [1 ]
机构
[1] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia
[2] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[3] WHO, HIV AIDS Dept, CH-1211 Geneva, Switzerland
[4] Ctr Dis Control & Prevent, Epidemiol & Strateg Informat Branch, Global AIDS Program, Atlanta, GA USA
[5] Ctr Dis Control & Prevent, Serol Incidence & Diagnost Team, GAP Int Lab Branch, Atlanta, GA USA
[6] Blood Syst Res Inst, San Francisco, CA USA
[7] Human Sci Res Council, Cape Town, South Africa
[8] S African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa
[9] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
关键词
CAPTURE ENZYME-IMMUNOASSAY; VIRUS TYPE-1 INFECTIONS; AVIDITY INDEX METHOD; ANTIRETROVIRAL THERAPY; TESTING ALGORITHM; PERFORMANCE-CHARACTERISTICS; SAN-FRANCISCO; SEROCONVERSION; SEROINCIDENCE; IDENTIFICATION;
D O I
10.1016/S1473-3099(09)70300-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We systematically reviewed the accuracy of serological tests for recent infections with HIV that have become widely used for measuring population patterns incidence of HIV. Across 13 different assays, sensitivity to detect recent infections ranged from 42-100% (median 89%). Specificity for detecting established infections was between 49.5% and 100% (median 86.8%) and was higher for infections of durations longer than 1 year (median 98%, range 31.5-100.0). For four different assays, comparisons were made between assay-derived population incidence estimates and a reference incidence estimate. The median percentage difference between the assay-derived incidence and reference incidence was 26.0%. Serological assays have reasonable sensitivity for the detection of recent infection with HIV, but are vulnerable to misclassifying established infections as recent-potentially leading to biases in incidence estimates. This conclusion is highly qualified by the apparent absence of a standardised approach to assay evaluation. There is an urgent need for an internationally agreed framework for evaluating and comparing these tests.
引用
收藏
页码:747 / 759
页数:13
相关论文
共 57 条
[1]  
ADONSUHOYI Y, 2006, STARHS WORKSH ASS 16
[2]  
[Anonymous], EURO SURVEILL
[3]   Evaluation of diagnostic tests for infectious diseases: general principles [J].
Banoo, Shabir ;
Bell, David ;
Bossuyt, Patrick ;
Herring, Alan ;
Mabey, David ;
Poole, Freddie ;
Smith, Peter G. ;
Sriram, N. ;
Wongsrichanalai, Chansudo ;
Linke, Ralf ;
O'Brien, Rick ;
Perkins, Mark ;
Cunningham, Jane ;
Matsoso, Precious ;
Nathanson, Carl Michael ;
Olliaro, Piero ;
Peeling, Rosanna W. ;
Ramsay, Andy .
NATURE REVIEWS MICROBIOLOGY, 2006, 4 (Suppl 12) :S20-S32
[4]   Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots [J].
Barin, F ;
Meyer, L ;
Lancar, W ;
Deveau, C ;
Gharib, M ;
Laporte, A ;
Desenclos, JC ;
Costagliola, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4441-4447
[5]  
BARIN F, 2008, EURO SURVEILL, V13
[6]  
Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43
[7]   A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Strong, DM ;
Caglioti, S ;
Wright, DJ ;
Pappalardo, B ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (02) :254-264
[8]  
*CDC, 2001, MMWR-MORBID MORTAL W, V50, P440
[9]   Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy [J].
Cimerman, Sergio ;
Araripe Sucupira, Maria Cecilia ;
Lewi, David Salomao ;
Diaz, Ricardo Sobhie .
AIDS PATIENT CARE AND STDS, 2007, 21 (02) :100-105
[10]   Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy [J].
Constantine, NT ;
Sill, AM ;
Jack, N ;
Kreisel, K ;
Edwards, J ;
Cafarella, T ;
Smith, H ;
Bartholomew, C ;
Cleghorn, FR ;
Blattner, WA .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (01) :94-103